IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

Authors

Rui André Saraiva RaposoFollow
Miguel de Mulder Rougvie
Dominic Paquin-Proulx
Phillip M Brailey
Vinicius D Cabido
Paul M Zdinak
Allison S ThomasFollow
Szu-Han HuangFollow
Greta A Beckerle
Richard B Jones
Douglas F. Nixon, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

1-12-2017

Journal

JCI Insight

Volume

2

Issue

1

Inclusive Pages

e85811

DOI

10.1172/jci.insight.85811

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Raposo, R., de Mulder Rougvie, M., Paquin-Proulx, D., Brailey, P., Cabido, V., Zdinak, P., Thomas, A., Huang, S., Beckerle, G., Jones, R., & Nixon, D. F. (2017). IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.. JCI Insight, 2 (1). http://dx.doi.org/10.1172/jci.insight.85811

Peer Reviewed

1

Open Access

1